| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/18/2009 | CN101389762A Gene promoters that can be used in plants |
| 03/18/2009 | CN101389759A De-differentiation of astrocytes into neural stem cell using shh |
| 03/18/2009 | CN101389750A Improved bacterial host cell for the direct expression of peptides |
| 03/18/2009 | CN101389653A Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
| 03/18/2009 | CN101389652A T cell receptors which specifically bind to VYGFVRACL-HLA-A24 |
| 03/18/2009 | CN101389651A Receptor-specific tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) variants |
| 03/18/2009 | CN101389650A Compositions comprising an acylated insulin and zinc and method of making the said compositions |
| 03/18/2009 | CN101389649A Polypeptide antagonist |
| 03/18/2009 | CN101389648A Oxyntomodulin derivatives |
| 03/18/2009 | CN101389647A Selective vpac2 receptor peptide agonists |
| 03/18/2009 | CN101389646A Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof |
| 03/18/2009 | CN101389645A Polypeptides having xylanase activity and polynucleotides encoding same |
| 03/18/2009 | CN101389644A Novel lipases and uses thereof |
| 03/18/2009 | CN101389643A Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 03/18/2009 | CN101389642A Cyclic antimicrobial peptides |
| 03/18/2009 | CN101389641A Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae |
| 03/18/2009 | CN101389346A Human glp-1 mimetibodies, compositions, methods and uses |
| 03/18/2009 | CN101389314A Bioactive fus1 peptides and nanoparticle-polypeptide complexes |
| 03/18/2009 | CN101386859A Tobacco wildfire pathogenic bacteria hrpZ gene and expression product and application thereof |
| 03/18/2009 | CN101386858A Rice plant type relevant gene RL10 and use thereof |
| 03/18/2009 | CN101386854A Tripolium vulgare nees tonoplast Na<+>/H<+> antiporter protein gene and amino acid sequence and gene preparation method and amplification primers |
| 03/18/2009 | CN101386853A Silkworm voltage-gated sodium channel gene, encoded protein and clone method thereof |
| 03/18/2009 | CN101386849A Nematode epidermal protein for anti-insect blood cell immunity and gene order |
| 03/18/2009 | CN101386651A Expression and export of angiostatin and endostatin as immunofusis |
| 03/18/2009 | CN101386646A Plant salt stress tolerant protein and encoding gene and application thereof |
| 03/18/2009 | CN101386645A Plant salt tolerant protein and encoding gene and application thereof |
| 03/18/2009 | CN101386644A Pumpkin protein 2 and preparation method and application thereof |
| 03/18/2009 | CN101386643A Expression of vibrio alginolyticus outer membrane protein VA0760 and application thereof as vaccine component |
| 03/18/2009 | CN101386642A Expression of vibrio alginolyticus outer membrane protein VA0760 and application thereof as vaccine component |
| 03/18/2009 | CN101386641A Synthetic peptide vaccines for foot-and-mouth disease |
| 03/18/2009 | CN101385854A Rabbit hemorrhagic disease vaccine and antigens |
| 03/18/2009 | CN101385851A Methods and compositions for healing and repair of articular cartilage |
| 03/18/2009 | CN101385467A Novel pesticidal toxins |
| 03/18/2009 | CN100469882C Preparation and use of conservative region of recombinant helicobacter pylori adhesin |
| 03/18/2009 | CN100469880C Genetic control of flowering |
| 03/18/2009 | CN100469878C Vascular adhesion molecules and modulation of their function |
| 03/18/2009 | CN100469875C Process for producing L-amino acid using escherichia |
| 03/18/2009 | CN100469793C Anti-osteopontin antibody and use thereof |
| 03/18/2009 | CN100469792C Regulation of lipid levels via the Zmaxl or HBM gene |
| 03/18/2009 | CN100469791C Glucagon-like peptide-1 analogs |
| 03/18/2009 | CN100469790C Production of recombinant BMP-2 |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/17/2009 | US7505135 Method and apparatus for imaging through scattering or obstructing media |
| 03/17/2009 | US7504569 Plants and seeds of hybrid corn variety CH672515 |
| 03/17/2009 | US7504568 Maize hybrid variety X5F802 |
| 03/17/2009 | US7504560 transgenic edible plants comprising a nucleotide construct, including promoters that preferentially targets expression to an edible tissue of the plant and untranslated signal sequences, that codes an immunogen of a recombinant animal viral antigen protein, that induces an immune responses |
| 03/17/2009 | US7504559 Protein kinase stress-related proteins and methods of use in plants |
| 03/17/2009 | US7504554 Injecting potential tumor cells into a transgenic mouse with a nucleic acid genome encoding the extracellular domain of humanized CTLA4 receptor; administering a candidate drug to the mouse; and monitoring tumor growth |
| 03/17/2009 | US7504491 An isolated DNA that codes for amino acid sequences having light absorbing properties but does not emit fluorescence or amino acid sequences having deletions, replacements or additions to the sequence, to modify it's light-absorbing properties and emits fluorescence, used for analysis |
| 03/17/2009 | US7504486 Determination and uses of the atomic structures of ribosomes and ribosomal subunits and their ligand complexes |
| 03/17/2009 | US7504484 Antibodies to the PRO1561 polypeptide |
| 03/17/2009 | US7504483 α-β C4BP-type recombinant heteromultimeric proteins |
| 03/17/2009 | US7504482 Recombinant soluble Fc receptors |
| 03/17/2009 | US7504481 TRP channel family member, LTRPC3 polypeptides |
| 03/17/2009 | US7504480 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 03/17/2009 | US7504479 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 03/17/2009 | US7504380 Antimicrobial peptide isolated from halocynthia aurantium |
| 03/17/2009 | US7504377 deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes in mammals and for treating disorders where oxygen delivery agents are of benefit |
| 03/17/2009 | US7504375 Antimicrobial polypeptides |
| 03/17/2009 | US7504254 Hybridomas; monoclonal antibodies do not cross-react with host tissue polysialic acid and pose minimal risk of autoimmune activity; vaccines; mimetics |
| 03/17/2009 | US7504253 Nucleotide sequences coding chimeric siah-mediated-degradation-proteins (SMDPs) comprising ornithine carboxylase degratory domain for use in diagnosis, prevention and treatment of cell proliferative disorders; kits |
| 03/17/2009 | US7504248 Production of viruses viral isolates and vaccines |
| 03/17/2009 | US7504242 Process for the fermentative production of amino acids using coryneform bacteria in which OpcA gene expression is amplified |
| 03/17/2009 | US7504237 Polynucleotides encoding interferon gamma polypeptides |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504229 Insecticides against coleopteran insects including red flour beetle larvae and Japanese beetle larvae (Popillia japonica); transgenic plants having genes encoding crystal protein or peptide; immunodetection kits |
| 03/17/2009 | US7504227 Screening agents for diminishing cellular toxicity associated with alpha-synuclein polypeptide of Parkinson's Disease; Huntington's Disease; inclusion bodies |
| 03/17/2009 | US7504224 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 03/17/2009 | US7504223 Using variation in annexin 7 (ANX7) gene expression as diagnostic tool in detection of mammary gland cell proliferative disorders |
| 03/17/2009 | US7504217 Non-structural protein 5A (NS5A); Hepatitis C virus; point mutations |
| 03/17/2009 | US7504211 Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 03/17/2009 | US7504206 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 03/17/2009 | US7504205 Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy |
| 03/17/2009 | US7504203 Method for assessing sensitivity of a rice blast fungus to a scytalone dehydratase inhibitor |
| 03/17/2009 | US7504111 Protein from gonococcus (Neisseria gonorrhoeae), including a specific amino acid sequence; antigens for vaccines, immunogenic compositions, and/or diagnostics; useful for distinguishing between gonococcus and meningococcus |
| 03/17/2009 | US7504109 Avian pandemic; immunogens; antibodies; immunology |
| 03/17/2009 | US7504108 Polypeptides; immunogenic compositions; generating immune responses; kits |
| 03/17/2009 | US7504105 Antibody for diagnosising immunology disorders |
| 03/17/2009 | US7504104 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens |
| 03/17/2009 | US7504099 Regeneration of tendons by grafting genetic engineered stem cells comprises nucleic acid coding for BMP-2 and SMAD proteins or variants |
| 03/17/2009 | US7504097 Interferon-alpha polypeptides and conjugates |
| 03/17/2009 | US7504087 Receptor-avid exogenous optical contrast and therapeutic agents |
| 03/17/2009 | CA2319094C Antimicrobial peptides |
| 03/17/2009 | CA2242574C Glutenin genes and their uses |
| 03/17/2009 | CA2171434C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 03/13/2009 | CA2597878A1 Capsid protein and use therefore |
| 03/12/2009 | WO2009033162A1 Gene targets in anti-aging therapy and tissue repair |
| 03/12/2009 | WO2009033074A2 De-duplication in virtualized server and virtualized storage environments |
| 03/12/2009 | WO2009032954A1 Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity |
| 03/12/2009 | WO2009032943A2 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 03/12/2009 | WO2009032664A2 Methods and compositions for increasing biological molecule stability |
| 03/12/2009 | WO2009032559A1 Novel 7s-alpha regulatory elements for expressing transgenes in plants |
| 03/12/2009 | WO2009032456A2 Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state |
| 03/12/2009 | WO2009031664A1 Gene participating in low temperature germinability in rice and utilization of the same |
| 03/12/2009 | WO2009031095A2 Multi-block copolymers |
| 03/12/2009 | WO2009030978A2 Conformers of bacterial adhesins |
| 03/12/2009 | WO2009030898A1 Method for the stabilisation of purified p-glycoprotein |
| 03/12/2009 | WO2009030884A2 Mannosylated butyrophilin tumour markers |
| 03/12/2009 | WO2009030872A1 Materials and methods for the treatment of hepatitis c |
| 03/12/2009 | WO2009030866A2 Method for purifying the factor viii and the von willebrand factor |